Abstract. AMP-activated protein kinase (AMPK) is firmly established as a central regulator of cellular energy homeostasis. We have previously reported that prostaglandin E 1 (PGE 1 ) stimulates the synthesis of osteoprotegerin through p38 mitogen-activated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in osteoblast-like MC3T3-E1 cells. The present study investigated the involvement of AMPK in PGE 1 -induced osteoprotegerin synthesis in MC3T3-E1 cells. The levels of osteoprotegerin were measured using an enzyme-linked immunosorbent assay, while the phosphorylation of AMPK, acetyl-CoA carboxylase, p38 MAP kinase and SAPK/JNK were analyzed by western blotting. In addition, the mRNA expression levels of osteoprotegerin were determined by a reverse transcription-quantitative polymerase chain reaction. It was revealed that PGE 1 significantly induced the phosphorylation of the α and β subunits of AMPK in a time-dependent manner (P<0.05). In addition, acetyl-CoA carboxylase, a direct substrate of AMPK, was significantly phosphorylated by PGE 1 (P<0.05). Compound C, an AMPK inhibitor, was revealed to suppress the phosphorylation of acetyl-CoA carboxylase, which significantly reduced the release and mRNA expression levels of PGE 1 -stimulated osteoprotegerin (P<0.05). However, the PGE 1 -induced phosphorylation of p38 MAP kinase and SAPK/JNK were not affected by compound C. The results of the present study indicated that AMPK may positively regulate PGE 1 -stimulated osteoprotegerin synthesis in osteoblasts; thus providing novel insight into the regulatory mechanisms underlying bone metabolism.
Introduction
Bone metabolism is coordinated by two types of functional cells, osteoblasts and osteoclasts (1) . The former cells are responsible for bone formation, whilst the latter cells are responsible for bone resorption. Thus, bone mass is sufficiently maintained by osteoclastic bone resorption followed by osteoblastic bone formation, a process termed bone remodeling (1) . Disordered bone remodeling causes an imbalance in the rates of bone resorption vs. bone formation, which may result in metabolic bone diseases, including osteoporosis (1) . It is at present recognized that AMP-activated protein kinase (AMPK) functions as a central regulator of cellular energy homeostasis (2, 3) . AMPK has been identified as an enzyme that catalyzes the phosphorylation of acetyl-CoA carboxylase, which regulates lipid synthesis (3) . AMPK activity is increased by the elevation of the AMP/ATP ratio in response to physiological and pathological stress, resulting in the restoration of the cellular enzyme balance through the activation of ATP-generating pathways and the suppression of ATP-utilizing pathways (4) . Therefore, evidence indicates that AMPK regulates metabolic homeostasis throughout the body (3) . With respect to AMPK in bone metabolism, it has been revealed that AMPK activation stimulates bone formation and bone mass (5) . We have previously demonstrated that vascular endothelial growth factor synthesis, which is induced by basic fibroblast growth factor, is positively regulated by AMPK in osteoblast-like MC3T3-E1 cells (6) . Conversely, AMPK limits the interleukin (IL)-1-stimulated synthesis of IL-6 via the inhibitor of κB/nuclear factor-κB (NF-κB) signaling pathway in MC3T3-E1 cells (7) . However, the roles of AMPK in osteoblasts remain undefined.
Prostaglandins are important autocrine/paracrine modulators in bone metabolism (8) , and include prostaglandin E 1 (PGE 1 ), which has been identified as a potent bone-resorptive agent (9) . It is currently accepted that osteoblasts are vital in the regulation of bone resorption through activation of receptor activator of NF-κB ligand (RANKL) (10) . Osteoprotegerin is a glycoprotein secreted from osteoblasts and is a member of the tumor necrosis factor receptor superfamily, in addition to RANK (11) . Osteoprotegerin binds to RANKL as a decoy receptor, thus preventing RANKL from binding to RANK. This results in the inhibition of osteoclastogenesis and the activation of osteoclasts (11) . Furthermore, RANKL knockout mice reportedly develop severe osteopetrosis (12) , suggesting that RANKL is an important regulator of osteoclastogenesis. The RANK/RANKL/osteoprotegerin axis is currently recognized as a major regulatory system for the formation and activation of osteoclasts (13) . Our recent study demonstrated that PGE 1 stimulates osteoprotegerin synthesis via the activation of p38 mitogen-activated protein (MAP) kinase and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), but not via the activation of p44/p42 MAP kinase, in osteoblast-like MC3T3-E1 cells (14) . However, the molecular mechanism underlying the PGE 1 -stimulated synthesis of osteoprotegerin in osteoblasts has yet to be elucidated.
In the present study, the involvement of AMPK in PGE 1 -induced osteoprotegerin synthesis was investigated in osteoblast-like MC3T3-E1 cells. The present study revealed that AMPK acts as a positive regulator in PGE 1 -stimulated osteoprotegerin synthesis in MC3T3-E1 cells. (Gaithersburg, MD, USA). An enhanced chemiluminescence western blotting detection system was purchased from GE Healthcare Life Sciences (Chalfont, UK). All other materials and chemicals were obtained from commercial sources. PGE 1 was dissolved in ethanol (Wako Pure Chemical Industries, Ltd., Osaka, Japan) and compound C was dissolved in dimethyl sulfoxide (Sigma-Aldrich). The maximum concentration of ethanol or dimethyl sulfoxide used was 0.1% to avoid interference with the assay for osteoprotegerin or western blot analysis.
Materials and methods

Materials
Cell culture. Cloned osteoblast-like MC3T3-E1 cells derived from newborn mouse calvaria in a previous study (15) were maintained as previously described (16) . Briefly, MC3T3-E1 cells were cultured in α-minimum essential medium (α-MEM) supplemented with 10% fetal bovine serum (FBS) at 37˚C in a humidified atmosphere of 5% CO 2 /95% air. The cells were seeded into 35-mm diameter dishes (5x10 4 cells/dish) or 90-mm diameter dishes (2x10 5 cells/dish) in α-MEM supplemented with 10% FBS. After 5 days, the medium was exchanged for α-MEM supplemented with 0.3% FBS. The cells were used for experiments following a 48-h incubation period at 37˚C.
Assay for osteoprotegerin. The cultured cells were pretreated with 0.1, 1, 3 or 10 µM compound C for 60 min. The cells were stimulated with 10 µM PGE 1 or vehicle [phosphate-buffered saline (PBS) supplemented with 0.01% bovine serum albumin (Sigma-Aldrich) containing 0.1% ethanol] in 1 ml α-MEM supplemented with 0.3% FBS, and then incubated for 48 h. The conditioned medium was collected by aspiration subsequent to incubation, followed by measurement with a mouse osteoprotegerin ELISA kit, according to the manufacturer's protocol.
Western blot analysis. The cultured cells were pretreated with 0.1, 1, 3 or 10 µM of compound C for 60 min, and then stimulated with 10 µM PGE 1 or vehicle in α-MEM supplemented with 0.3% FBS for 0, 1, 3, 5, 10, 20, 30 or 60 min. The cells were washed twice with PBS and then lysed, homogenized and sonicated in 900 µl lysis buffer containing 62.5 mM Tris/HCl (pH 6.8), 2% sodium dodecyl sulfate (SDS), 50 mM dithiothreitol and 10% glycerol. Protein samples were obtained from the lysed cells using a cell scraper, after which equal quantities of protein (10 µl) were separated by SDS-polyacrylamide gel electrophoresis, according to a previous study (17) , on 10% polyacrylamide gels. The electrophoresis was run at 100 V for the separating gel and 250 V for the stacking gel, until the dye front ran off the bottom of the gel. The protein was fractionated and transferred to an Immun-Blot polyvinylidene difluoride (PVDF) membrane (Bio-Rad Laboratories, Hercules, CA, USA). Western blot analysis was performed as previously described (18) . Briefly, the membranes were blocked with 5% fat-free dry milk in Tris-buffered saline containing Tween-20 (TBST; 20 mM Tris/HCl, pH 7.6, 137 mM NaCl, 0.1% Tween-20) for 1 h prior to incubation with the primary antibodies. The membranes were incubated overnight at 4˚C with the rabbit anti-p-AMPK, anti-acetyl-CoA carboxylase, anti-GAPDH, anti-p-p38 MAP kinase, anti-p38 MAP kinase, anti-p-SAPK/JNK and anti-SAPK/JNK primary antibodies at a dilution of 1:1,000 in 5% milk containing TBST. Subsequently, the membranes were washed three times for 5 min each with TBST, and then incubated for 1 h at room temperature with peroxidase-conjugated goat anti-rabbit IgG at a dilution of 1:1,000 in 5% milk containing TBST. Peroxidase activity on the PVDF membrane was visualized on X-ray film (Super RX; FUJIFILM, Kanagawa, Japan) by means of the enhanced chemiluminescence western blotting detection system.
Densitometric analysis. Densitometric analysis of the western blots was performed using a scanner (GT-F600; Seiko Epson Corporation, Nagano, Japan) and Image J image analysis software program (version 1.48; National Institutes of Health, Bethesda, MD, USA). The background-subtracted signal intensity for each phosphorylation signal was normalized to the respective total protein signal, and plotted as the fold increase in comparison to control cells that did not receive stimulation.
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
The cultured cells were pretreated with 10 µM compound C or vehicle for 60 min, and then stimulated with 10 µM of PGE 1 or vehicle in α-MEM supplemented with 0.3% FBS for 3 h. Total RNA was isolated and reverse transcribed into cDNA using TRIzol reagent (Invitrogen; Thermo Fisher Scientific, Inc.) and an Omniscript Reverse Transcriptase kit (Qiagen, Inc., Valencia, CA, USA), respectively. RT-qPCR was performed in capillaries using a LightCycler ® 480 system with the LightCycler FastStart DNA Master SYBR Green I (Roche Diagnostics, Basel, Switzerland) and 1 ml cDNA. The primer sequences were as follows: Osteoprotegerin forward, 5'-CAA TGG CTG GCT TGG TTT CAT AG-3' and reverse, 5'-CTG AAC CAG ACA TGA CAG CTG GA-3' (Takara Bio, Inc., Otsu, Japan); and GAPDH forward, 5'-AAC GAC CCC TTC ATT GAC-3' and reverse, 5'-TCC ACG ACA TAC TCA GCA C-3' (Sigma-Aldrich). The reaction mixtures were incubated at 95˚C for 10 min, followed by 40 cycles at 60˚C for 5 sec and 72˚C for 7 sec. The amplified products were confirmed by a melting curve analysis, according to the system protocol. The osteoprotegerin mRNA expression levels were normalized to those of GAPDH mRNA using PASW Statistics software, version 18 (SPSS, Inc., Chicago, IL, USA) and the relative mRNA expression levels were determined from the basis of a standard curve, which was created automatically with the LightCycler software in each run. The results are the average of three independent experiments.
Statistical analysis. The data were analyzed by analysis of variance followed by the Bonferroni method for multiple comparisons between pairs. P<0.05 was considered to indicate a statistically significant difference. Statistical analyses were conducted using Microsoft Office Excel 2013 for Windows (Microsoft, Redmond, WA, USA) Data are presented as the means ± standard error of the mean of triplicate determinations from three independent cell preparations.
Results
PGE 1 induces the phosphorylation of AMPK and acetyl-CoA carboxylase in MC3T3-E1 cells.
It is firmly established that the phosphorylation of AMPK is necessary for its activation (19) . Therefore, to determine whether AMPK is activated by PGE 1 in osteoblast-like MC3T3-E1 cells, the present study initially examined the effect of PGE 1 on the phosphorylation of AMPK (Fig. 1A) . PGE 1 significantly induced the phosphorylation of AMPKα (Thr-172; P<0.05; Fig. 1B) and AMPKβ (Ser-108; P<0.05; Fig. 1C ). The effects of PGE 1 on the phosphorylation of AMPKα and AMPKβ reached peak levels at 1 and 5 min after stimulation, respectively; and decreased thereafter. Subsequent to this, as acetyl-CoA carboxylase is a direct substrate of AMPK (3), the effect of PGE 1 on the phosphorylation of acetyl-CoA carboxylase in MC3T3-E1 cells was examined. PGE 1 significantly stimulated the phosphorylation of acetyl-CoA carboxylase, displaying peak levels 3 min after stimulation (Fig. 1D) .
Compound C suppresses PGE 1 -stimulated osteoprotegerin release in MC3T3-E1 cells. Our previous study recently revealed that PGE 1 stimulates osteoprotegerin synthesis in osteoblast-like MC3T3-E1 cells (14) . In order to investigate the involvement of AMPK in PGE 1 -induced synthesis of osteoprotegerin in the aforementioned cells, the effect of compound C, 
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an AMPK inhibitor (20) , on PGE 1 -stimulated release of osteoprotegerin was examined. Compound C significantly suppressed PGE 1 -stimulated osteoprotegerin release compared with cells treated with PGE 1 alone (P<0.05; Fig. 2A ). The inhibitory effect of compound C was dose-dependent between 0.1 and 10 mM (Fig. 2B) . The maximum suppressive activity of compound C was observed at 10 µM, producing 60% inhibition of the effects of PGE 1 . A B Figure 4 . Effect of compound C on PGE 1 -induced OPG mRNA expression in MC3T3-E1 cells. The cultured cells were pretreated with 10 µM compound C or vehicle for 60 min, and then stimulated by 10 µM PGE 1 or vehicle for 3 h. The respective total RNA was then isolated and quantified by reverse transcription-quantitative polymerase chain reaction. Each value represents the mean ± standard error of the mean of triplicate determinations from three independent cell preparations. Figure 3 . Effect of compound C on PGE 1 -stimulated phosphorylation of acetyl-CoA carboxylase in MC3T3-E1 cells. The cultured cells were pretreated with 10 µM compound C or vehicle for 60 min, and then stimulated with 10 µM of PGE 1 or vehicle for 3 min. The extracts of cells were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis with subsequent western blot analysis using phospho-specific acetyl-CoA carboxylase antibodies or GAPDH. The histogram indicates the quantification of the levels of the PGE 1 -induced phosphorylation obtained from laser densiometric analysis of three independent experiments. The phosphorylation levels were corrected by the GAPDH expression levels, and are presented as the fold increase with respect to the basal levels presented in lane 1. Each value represents the mean ± standard error of the mean of triplicate determinations from three independent cell preparations. Additionally, the effect of compound C on PGE 1 -induced phosphorylation of acetyl-CoA carboxylase in MC3T3-E1 cells was examined. PGE 1 -induced phosphorylation of acetyl-CoA carboxylase was significantly reduced by compound C compared with PGE 1 treatment alone (P<0.05; Fig. 3 ).
Compound C suppresses PGE 1 -induced osteoprotegerin mRNA expression levels in MC3T3-E1 cells. To determine whether the inhibition of the PGE 1 -stimulated osteoprotegerin release by compound C is mediated through transcriptional events in osteoblast-like MC3T3-E1 cells, the effect of compound C on PGE 1 -induced osteoprotegerin mRNA expression levels were examined by RT-qPCR. The expression levels of osteoprotegerin mRNA induced by PGE 1 were significantly suppressed by compound C compared with PGE 1 treatment alone (P<0.05; Fig. 4 ).
Compound C does not affect PGE 1 -stimulated phosphorylation of p38 MAP kinase or SAPK/JNK in MC3T3-E1 cells.
Regarding the intracellular signaling of PGE 1 in osteoblasts, our previous study revealed that PGE 1 induces the activation of p44/p42 MAP kinase, p38 MAP kinase and SAPK/JNK in osteoblast-like MC3T3-E1 cells. In addition, p38 MAP kinase and SAPK/JNK were implicated in PGE 1 -stimulated osteoprotegerin synthesis, whilst p44/p42 MAP kinase was not (14) . To investigate whether the effect of AMPK on PGE 1 -stimulated osteoprotegerin synthesis is associated with the activation of p38 MAP kinase or SAPK/JNK in MC3T3-E1 cells, the effects of compound C on PGE 1 -induced phosphorylation of p38 MAP kinase and SAPK/JNK were examined. However, compound C did not affect PGE 1 -induced phosphorylation of p38 MAP kinase (Fig. 5A) or SAPK/JNK (Fig. 5B ) between 1 and 10 µM.
Discussion
The present study revealed that PGE 1 significantly stimulates the phosphorylation of AMPKα (Thr-172) and AMPKβ (Ser-108) in osteoblast-like MC3T3-E1 cells. The heterotrimeric AMPK complex is comprised of α, β and γ subunits (2) . Of the aforementioned subunits of AMPK, the α subunit is a catalytic subunit. Conversely, the β and γ subunits are regulatory subunits (19) . It is currently recognized that the phosphorylation of Thr-172, located within the α subunit, is required for AMPK activity, while phosphorylation of the β subunit is necessary for the activation of AMPK (19) . The present study revealed that the phosphorylation of acetyl-CoA carboxylase was significantly induced by PGE 1 in MC3T3-E1 cells. It is generally accepted that activated AMPK induces the phosphorylation of acetyl-CoA carboxylase, a direct substrate of AMPK, resulting in the stimulation of the oxidation of fatty acid as a result of its inhibition (3). The maximum effect of PGE 1 on the phosphorylation of acetyl-CoA carboxylase was observed 3 min after stimulation. Comparatively, the α subunit demonstrated peak phosphorylation levels within 1 min. Thus, the time course of AMPKα phosphorylation appeared to be more rapid than that of acetyl-CoA carboxylase. As a result, PGE 1 -induced activation of acetyl-CoA carboxylase occurs subsequent to AMPKα activation. Considering the findings of the present study, it is possible that PGE 1 induces AMPK activation in osteoblast-like MC3T3-E1 cells.
Our previous study recently reported that PGE 1 stimulates osteoprotegerin synthesis in osteoblast-like MC3T3-E1 cells (14) . The involvement of AMPK in osteoprotegerin synthesis has since been investigated, and it was revealed that the PGE 1 -stimulated release of osteoprotegerin was significantly suppressed by compound C in MC3T3-E1 cells (20) . In agreement, the present study revealed that compound C was able to inhibit PGE 1 -induced phosphorylation of acetyl-CoA carboxylase in these cells. Therefore, it is possible that PGE 1 -activated AMPK is involved in osteoprotegerin release. Additionally, the present study demonstrated that PGE 1 -induced mRNA expression levels of osteoprotegerin were significantly downregulated by compound C, suggesting that the effect of compound C is exerted through inhibition of the transcriptional process. Based on the findings of the present study, it is proposed that PGE 1 stimulates AMPK activation, resulting in the induction of osteoprotegerin synthesis in osteoblast-like MC3T3-E1 cells.
With regard to the intracellular signaling of PGE 1 in osteoblasts, our previous study demonstrated that PGE 1 induces the activation of p44/p42 MAP kinase, p38 MAP kinase and SAPK/JNK in osteoblast-like MC3T3-E1 cells (21, 22) , and that p38 MAP kinase and SAPK/JNK (but not p44/p42 MAP kinase) are involved in PGE 1 -stimulated osteoprotegerin synthesis (14) . The MAP kinase superfamily have a crucial role in various cellular functions, including proliferation, differentiation and survival (23) . It is generally recognized that p38 MAP kinase, p44/p42 MAP kinase and SAPK/JNK are three major MAP kinases necessary for the transduction of diverse cellular messages (24) . In order to investigate the molecular A B mechanism employed by AMPK in PGE 1 -stimulated osteoprotegerin synthesis in MC3T3-E1 cells, the association between AMPK and the aforementioned MAP kinases were investigated. However, the present study revealed that compound C failed to effect the PGE 1 -induced phosphorylation of p38 MAP kinase or SAPK/JNK. Therefore, it is likely that AMPK may act downstream of the aforementioned MAP kinases, or through a different target located upstream of transcription, resulting in osteoprotegerin synthesis. Further investigation is required to identify the exact mechanism by which AMPK is involved in PGE 1 -stimulated osteoprotegerin synthesis in osteoblasts.
It is currently established that AMPK has a central role in energy homeostasis, particularly in myocytes and adipocytes (2) . Regarding the roles of AMPK in osteoblasts, it has been revealed that the activation of AMPK stimulates collagen synthesis and the induction of Runt-related transcription factor 2 expression, and enhances mineralization (25, 26) . Additionally, AMPK has been reported to have an inhibitory role in palmitate-induced apoptosis (27) . Thus, accumulating evidence suggests that AMPK activation in osteoblasts may stimulate them toward differentiation. It is accepted that PGE 1 acts as an autocrine/paracrine regulator of osteoblasts and also regulates bone remodeling (8) . Conversely, it is established that osteoprotegerin acts as a decoy receptor to prevent RANKL from binding RANK in osteoclast progenitor cells, resulting in the downregulation of osteoclastogenesis and bone resorption (11) . Based on the findings of the present study, it is proposed that AMPK activated by PGE 1 in osteoblasts directs the bone remodeling process to favor formation rather than resorption by stimulating osteoprotegerin synthesis. Further investigation is necessary to elucidate the exact roles of AMPK in bone metabolism.
In conclusion, the results of the present study strongly suggest that AMPK positively regulates the PGE 1 -stimulated synthesis of osteoprotegerin in osteoblasts. The present study may provide novel insights into the regulatory mechanisms underlying bone metabolism.
